Verrica Pharmaceuticals Inc - VRCA - stock price prediction, stock price target, analyst ratings from 4 analysts

Verrica Pharmaceuticals Inc has a share price target of US$ 15, revenue growth forecast of 323.8%, and profit growth estimate of 68.9% for FY25, based on top 4 analyst calls.